Dystroglycan expression in human placenta: basement membrane localization and subunit distribution change between the...

Area of Science:

• Reproductive biology
• Cellular and molecular biology
• Biochemistry

Background:

• Dystroglycan (DG) is a key component of the dystrophin-glycoprotein complex.
• Its role in placental development and function is not fully understood.
• Aberrant DG expression is implicated in various disease states.

Purpose of the Study:

• To investigate the distribution and expression patterns of dystroglycan (DG) subunits (α-DG and β-DG) in human placenta, membranes, and decidua.
• To correlate DG expression with trophoblast differentiation and gestational age.

Main Methods:

• Western blotting was used to assess DG protein levels.
• Immunohistochemistry and immunofluorescence microscopy were employed to determine the cellular and subcellular localization of α-DG and β-DG.
• Human placental tissues, fetal membranes, decidua, and cultured cells (including choriocarcinoma and HTR cells) were analyzed.

Main Results:

• Both α-DG and β-DG were detected in the syncytiotrophoblast of term placenta, with α-DG localized to the basement membrane.
• In first-trimester chorionic villi, α-DG and β-DG were found at the periphery of the cytotrophoblast.
• DG expression patterns varied in term fetal membranes; α-DG was undetectable in choriocarcinoma and HTR cells, while β-DG was present.

Conclusions:

• Dystroglycan is expressed at high levels in human trophoblasts.
• The localization of α-DG and β-DG subunits changes with gestational age and trophoblast differentiation.
• The observed expression pattern suggests a potential role for DG in inhibiting placental invasion, analogous to its function in cancer.